ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Sawvic
|
11K |
5.3M |
19 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
11K
|
5.3M
|
19
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
Sawvic
|
1.3K |
691K |
34 |
08/06/24 |
08/06/24 |
ASX - By Stock
|
1.3K
|
691K
|
34
|
|
ASX - By Stock
|
CVB |
Re:
CVB Media Links
|
|
Sawvic
|
10 |
5.7K |
2 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
10
|
5.7K
|
2
|
|
ASX - By Stock
|
CVB |
Re:
CVB Media Links
|
|
Sawvic
|
10 |
5.7K |
2 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
10
|
5.7K
|
2
|
|
ASX - By Stock
|
CYC |
Re:
Ann: Trading Halt
|
|
Sawvic
|
17 |
3.8K |
1 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
17
|
3.8K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Sawvic
|
11K |
5.3M |
20 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
11K
|
5.3M
|
20
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
Sawvic
|
1.3K |
691K |
3 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
1.3K
|
691K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
Sawvic
|
1.3K |
691K |
34 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
1.3K
|
691K
|
34
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
Sawvic
|
1.3K |
691K |
2 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
1.3K
|
691K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
Sawvic
|
1.3K |
691K |
17 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
1.3K
|
691K
|
17
|
|
ASX - By Stock
|
CYC |
Re:
Ann: Becoming a substantial holder
|
|
Sawvic
|
15 |
4.5K |
1 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
15
|
4.5K
|
1
|
|
ASX - By Stock
|
CYC |
Re:
Ann: Becoming a substantial holder
|
|
Sawvic
|
15 |
4.5K |
4 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
15
|
4.5K
|
4
|
|
ASX - By Stock
|
CYC |
Re:
Ann: Becoming a substantial holder
|
|
Sawvic
|
15 |
4.5K |
0 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
15
|
4.5K
|
0
|
|
ASX - By Stock
|
ADR |
Re:
Ann: US FDA clearance of Hailie for AstraZeneca inhalers
|
|
Sawvic
|
75 |
21K |
1 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
75
|
21K
|
1
|
|
ASX - By Stock
|
HXL |
Re:
Ann: Receipt of R&D Tax Refund
|
|
Sawvic
|
4 |
2.5K |
1 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
4
|
2.5K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Neuren - where to from here ?
|
|
Sawvic
|
91 |
55K |
29 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
91
|
55K
|
29
|
|
ASX - By Stock
|
NEU |
Re:
Neuren - where to from here ?
|
|
Sawvic
|
91 |
55K |
1 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
91
|
55K
|
1
|
|
ASX - By Stock
|
NEU |
Neuren - where to from here ?
|
|
Sawvic
|
91 |
55K |
96 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
91
|
55K
|
96
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
Sawvic
|
1.3K |
691K |
1 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
1.3K
|
691K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
Sawvic
|
1.3K |
691K |
10 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
1.3K
|
691K
|
10
|
|
Charts
|
NEU |
Re:
Positive Reports
|
|
Sawvic
|
41 |
18K |
92 |
03/03/24 |
03/03/24 |
Charts
|
41
|
18K
|
92
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
Sawvic
|
818 |
383K |
43 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
818
|
383K
|
43
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
Sawvic
|
818 |
383K |
10 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
818
|
383K
|
10
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Comment on research report
|
|
Sawvic
|
316 |
168K |
5 |
18/02/24 |
18/02/24 |
ASX - By Stock
|
316
|
168K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Comment on research report
|
|
Sawvic
|
316 |
168K |
27 |
18/02/24 |
18/02/24 |
ASX - By Stock
|
316
|
168K
|
27
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
Sawvic
|
818 |
383K |
40 |
17/02/24 |
17/02/24 |
ASX - By Stock
|
818
|
383K
|
40
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Comment on research report
|
|
Sawvic
|
316 |
168K |
10 |
17/02/24 |
17/02/24 |
ASX - By Stock
|
316
|
168K
|
10
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Comment on research report
|
|
Sawvic
|
316 |
168K |
15 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
316
|
168K
|
15
|
|
ASX - By Stock
|
CVB |
Re:
CVB Media Links
|
|
Sawvic
|
10 |
5.7K |
2 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
10
|
5.7K
|
2
|
|
ASX - By Stock
|
CYC |
Re:
Ann: Cyclopharm Trading and USA Launch Update
|
|
Sawvic
|
31 |
9.6K |
10 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
31
|
9.6K
|
10
|
|
ASX - By Stock
|
NEU |
Re:
Merck to acquire Prometheus in a US$ 10.8 b deal
|
|
Sawvic
|
108 |
65K |
34 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
108
|
65K
|
34
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Ceasing to be a substantial holder
|
|
Sawvic
|
8 |
2.2K |
0 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
8
|
2.2K
|
0
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Ceasing to be a substantial holder
|
|
Sawvic
|
8 |
2.2K |
2 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
8
|
2.2K
|
2
|
|
ASX - By Stock
|
CYC |
Re:
Ann: Cyclopharm Signs First USA Contract for Technegas
|
|
Sawvic
|
39 |
15K |
0 |
03/01/24 |
03/01/24 |
ASX - By Stock
|
39
|
15K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
Sawvic
|
315 |
160K |
0 |
15/12/23 |
15/12/23 |
ASX - By Stock
|
315
|
160K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
A De-risked bio-tech with 4X upside - Karst Peak Capital
|
|
Sawvic
|
73 |
44K |
12 |
12/12/23 |
12/12/23 |
ASX - By Stock
|
73
|
44K
|
12
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Sawvic
|
11K |
5.3M |
36 |
27/11/23 |
27/11/23 |
ASX - By Stock
|
11K
|
5.3M
|
36
|
|
ASX - By Stock
|
CVB |
Re:
CVB Media Links
|
|
Sawvic
|
10 |
5.7K |
0 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
10
|
5.7K
|
0
|
|
ASX - By Stock
|
CVB |
Re:
Ann: Quarterly Activities Webinar Presentation - Sep 2023 Qtr
|
|
Sawvic
|
7 |
5.0K |
1 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
7
|
5.0K
|
1
|
|
ASX - By Stock
|
CVB |
Re:
Ann: Quarterly Activities Webinar Presentation - Sep 2023 Qtr
|
|
Sawvic
|
7 |
5.0K |
1 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
7
|
5.0K
|
1
|
|
ASX - By Stock
|
CYC |
Re:
Ann: FDA Technegas Approval Webinar
|
|
Sawvic
|
64 |
18K |
2 |
15/10/23 |
15/10/23 |
ASX - By Stock
|
64
|
18K
|
2
|
|
ASX - By Stock
|
CVB |
Re:
Expectations - short term
|
|
Sawvic
|
29 |
17K |
0 |
03/10/23 |
03/10/23 |
ASX - By Stock
|
29
|
17K
|
0
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Investor Presentation
|
|
Sawvic
|
1 |
659 |
0 |
03/10/23 |
03/10/23 |
ASX - By Stock
|
1
|
659
|
0
|
|
ASX - By Stock
|
CYC |
Re:
Ann: Cyclopharm Receives USFDA Approval for Technegas
|
|
Sawvic
|
41 |
11K |
6 |
02/10/23 |
02/10/23 |
ASX - By Stock
|
41
|
11K
|
6
|
|
ASX - By Stock
|
CYC |
Re:
Countdown
|
|
Sawvic
|
65 |
19K |
0 |
01/10/23 |
01/10/23 |
ASX - By Stock
|
65
|
19K
|
0
|
|
ASX - By Stock
|
CYC |
Re:
Countdown
|
|
Sawvic
|
65 |
19K |
0 |
30/09/23 |
30/09/23 |
ASX - By Stock
|
65
|
19K
|
0
|
|
ASX - By Stock
|
CYC |
Re:
Countdown
|
|
Sawvic
|
65 |
19K |
4 |
30/09/23 |
30/09/23 |
ASX - By Stock
|
65
|
19K
|
4
|
|
ASX - By Stock
|
CYC |
Re:
Countdown
|
|
Sawvic
|
65 |
19K |
2 |
30/09/23 |
30/09/23 |
ASX - By Stock
|
65
|
19K
|
2
|
|
ASX - By Stock
|
CYC |
Re:
Countdown
|
|
Sawvic
|
65 |
19K |
2 |
30/09/23 |
30/09/23 |
ASX - By Stock
|
65
|
19K
|
2
|
|
ASX - By Stock
|
CYC |
Re:
Countdown
|
|
Sawvic
|
65 |
19K |
0 |
30/09/23 |
30/09/23 |
ASX - By Stock
|
65
|
19K
|
0
|
|